Despite recent declines, we believe Pfizer stock is a compelling buy right now, with its current price of around $23 likely reflecting existing concerns.

Pfizer is facing significant ... business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results.

The stock price dropped after the Q2 earnings release despite strong performance ... fair given that Pfizer's YoY and FWD revenue growth is deeply negative. Looking at peer analysis of valuation ...

My final reason for buying more Pfizer stock is that I'll get paid nicely to wait and see if the drugmaker lives up to Wall Street's growth outlook. Pfizer's forward dividend yield currently stands at ...

Its dividend: The stock recently yielded a whopping 7.3%. That's hard to beat and will generate around $730 for every $10,000 you have invested in Pfizer. CFO David Denton called the company’s ...

Pfizer demonstrated strong financial performance ... will be crucial in shaping its future market position and stock performance. With a beta of 0.57 indicating lower volatility than the market ...

Pfizer Inc. (NYSE:PFE), one of the ... According to InvestingPro analysis, the stock currently appears undervalued compared to its Fair Value estimate, presenting a potential opportunity for ...

Our detailed analysis of Pfizer’s upside post-inflation shock ... It compares these trends to the stock’s performance during the 2008 recession. In contrast, here’s how PFE stock and the ...

The recent formation of the FIBRE Consortium, a collaboration involving Pfizer (NYSE:PFE) and other pharmaceutical partners, ...